Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions

Millares,Laura; Rosell,Antoni; Setó,Laia; Sanz,José; Andreo,Felipe; Monsó,Eduard

doi:10.3892/or.2014.3364

Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions

Authors:
- Laura Millares
- Antoni Rosell
- Laia Setó
- José Sanz
- Felipe Andreo
- Eduard Monsó
View Affiliations

Affiliations: Fundació Parc Taulí, Sabadell/Badalona, Spain, CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain
Published online on: July 28, 2014 https://doi.org/10.3892/or.2014.3364
Pages: 1435-1440

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Assessment of the methylation status of genes related to the development of lung cancer (LC) in bronchial secretions has been proposed as a biomarker for early detection. Several techniques are available to detect gene methylation, and the method chosen may have an effect on the results. A cross-sectional study was conducted in which the methylation status of DAPK, CDKN2A (p16) and RASSF1A genes in sputum and bronchial washing (BW) from subjects at risk for LC was analyzed. The methylation results of both samples were compared, considering BW as the reference. Results obtained by methylation-sensitive PCR (MSP) were validated by methylation-sensitive high-resolution melting (MS-HRM). The methylation results obtained in sputum and BW samples did not show statistically significant differences for any of the three genes analyzed in 65 subjects (McNemar test >0.05). Concordant results between sputum and BW were found in 40 patients for DAPK (61%), in 52 patients for p16 (80%) and in 63 patients for RASSF1 (97%). More methylated samples were found in BW, however, and sputum sensitivities and specificities for the identification of methylation status were 44 and 72% for DAPK gene, 21 and 94% for p16 and 100 and 98% for RASSF1A, respectively. When MSP results were validated by MS-HRM, DAPK and p16 gene samples methylated by MSP appeared to be unmethylated by MS-HRM. One sample showing methylation of RASSF1A gene also showed methylation when tested following MS-HRM procedure. Sputum and BW samples may be considered equally valid for the identification of methylated genes in bronchial secretions. The low sensitivity of sputum for the assessment of the methylation status of DAPK and p16 genes, however, suggests that the analysis of two or more sputum samples, or of a BW obtained semi-invasively, would be needed to attain higher reliability, together with the use of confirmatory techniques for positive results.

View Figures

View References

1	Adcock IM, Tsaprouni L, Bhavsar P and Ito K: Epigenetic regulation of airway inflammation. Curr Opin Immunol. 19:694–700. 2007. View Article : Google Scholar : PubMed/NCBI
2	Barlesi F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P, et al: Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol. 25:4358–4364. 2007. View Article : Google Scholar : PubMed/NCBI
3	Leng S, Do K, Yingling CM, Picchi MA, Wolf HJ, Kennedy TC, et al: Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res. 18:3387–3395. 2012. View Article : Google Scholar : PubMed/NCBI
4	Malentacchi F, Forni G, Vinci S and Orlando C: Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol. Nucleic Acids Res. 37:e862009. View Article : Google Scholar : PubMed/NCBI
5	Mikeska T, Bock C, Do H and Dobrovic A: DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Rev Mol Diagn. 12:473–487. 2012. View Article : Google Scholar : PubMed/NCBI
6	Anglim PP, Alonzo TA and Laird-Offringa IA: DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer. 7:812008. View Article : Google Scholar : PubMed/NCBI
7	Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, et al: Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol. 22:2363–2370. 2004. View Article : Google Scholar : PubMed/NCBI
8	Hubers AJ, van der Drift MA, Prinsen CF, Witte BI, Wang Y, Shivapurkar N, et al: Methylation analysis in spontaneous sputum for lung cancer diagnosis. Lung Cancer. 84:127–133. 2014. View Article : Google Scholar : PubMed/NCBI
9	Fahy JV, Wong H, Liu J and Boushey HA: Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med. 152:53–58. 1995. View Article : Google Scholar : PubMed/NCBI
10	Kristensen LS and Hansen LL: PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem. 55:1471–1483. 2009. View Article : Google Scholar : PubMed/NCBI
11	Mikeska T, Candiloro IL and Dobrovic A: The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics. 2:561–573. 2010. View Article : Google Scholar : PubMed/NCBI
12	Warnecke PM, Stirzaker C, Song J, Grunau C, Melki JR and Clark SJ: Identification and resolution of artifacts in bisulfite sequencing. Methods. 27:101–107. 2002. View Article : Google Scholar : PubMed/NCBI
13	Lorente A, Mueller W, Urdangarin E, Lazcoz P, von Deimling A and Castresana JS: Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer. 8:612008. View Article : Google Scholar : PubMed/NCBI
14	Kristensen LS, Mikeska T, Krypuy M and Dobrovic A: Sensitive melting analysis after real time-methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res. 36:e422008. View Article : Google Scholar : PubMed/NCBI
15	Kristensen LS, Wojdacz TK, Thestrup BB, Wiuf C, Hager H and Hansen LL: Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer. 9:4532009.PubMed/NCBI
16	Do H, Krypuy M, Mitchell PL, Fox SB and Dobrovic A: High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies. BMC Cancer. 8:1422008. View Article : Google Scholar : PubMed/NCBI
17	Wojdacz TK, Dobrovic A and Hansen LL: Methylation-sensitive high-resolution melting. Nat Protoc. 3:1903–1908. 2008. View Article : Google Scholar
18	Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE and Dolovich J: Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 47:25–29. 1992. View Article : Google Scholar : PubMed/NCBI
19	Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 154:308–317. 1996. View Article : Google Scholar : PubMed/NCBI
20	Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al: British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults. Thorax. 68:i1–i44. 2013.
21	Reed AP: Preparation of the patient for awake flexible fiberoptic bronchoscopy. Chest. 101:244–253. 1992. View Article : Google Scholar : PubMed/NCBI
22	Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
23	Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, et al: Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62:2370–2377. 2002.PubMed/NCBI
24	Smith E, Jones ME and Drew PA: Quantitation of DNA methylation by melt curve analysis. BMC Cancer. 9:1232009. View Article : Google Scholar : PubMed/NCBI
25	Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al: Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 66:3338–3344. 2006. View Article : Google Scholar : PubMed/NCBI
26	Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, et al: Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer. 96:1278–1283. 2007. View Article : Google Scholar : PubMed/NCBI
27	Candiloro IL, Mikeska T and Dobrovic A: Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics. 6:500–507. 2011. View Article : Google Scholar : PubMed/NCBI
28	Wojdacz TK and Dobrovic A: Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 35:e412007. View Article : Google Scholar : PubMed/NCBI
29	Shen L, Guo Y, Chen X, Ahmed S and Issa JP: Optimizing annealing temperature overcomes bias in bisulfite PCR methylation analysis. Biotechniques. 42:48–58. 2007. View Article : Google Scholar : PubMed/NCBI